Filed (PHiled). Greater than 1-2 years since publication

CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia

Sajeth Dinakaran, Sima Qutaina, Haitian Zhao, Yuefeng Tang, Zhimin Wang, Santiago Ruiz, Aya Nomura-Kitabayashi, Christine N. Metz, Helen M. Arthur, Stryder M. Meadows, Lionel Blanc, Marie E. Faughnan, Philippe MarambaudFeinstein Institutes for Medical Research and Northwell Health. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Institut Pasteur de Montevideo. Newcastle University. Tulane University. Cohen […]

CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia Read More »

Brain and lung arteriovenous malformation rescreening practices for children and adults with hereditary hemorrhagic telangiectasia

Lauren A. Beslow, Helen Kim, Steven W. Hetts, Felix Ratjen, Marianne S. Clancy, James R. Gossage, Marie E. FaughnanChildren’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania. University of California San Francisco. Hospital for Sick Children and University of Toronto. Cure HHT Foundation. Augusta University. St. Michael’s Hospital.United States and

Brain and lung arteriovenous malformation rescreening practices for children and adults with hereditary hemorrhagic telangiectasia Read More »

Glenn circulation causes early and progressive shunting in a surgical model of pulmonary arteriovenous malformations

Tina C. Wan, Henry Rousseau, Carol Mattern, Madeline Tabor, Matthew R. Hodges, Ramani Ramchandran, Andrew D. SpearmanMedical College of Wisconsin and Children’s Wisconsin.United States Physiological ReportsPhysiol Rep 2024; 12: DOI: 10.14814/phy2.70123 AbstractPulmonary arteriovenous malformations (PAVMs) universally develop in patients with single ventricle congenital heart disease. Single ventricle PAVMs have been recognized for over 50 years but

Glenn circulation causes early and progressive shunting in a surgical model of pulmonary arteriovenous malformations Read More »

Experience of patent ductus arteriosus ligation during extracorporeal membrane oxygenation treatment in newborns with severe respiratory failure due to persistent pulmonary hypertension: a single-center retrospective study

Qi-Liang Zhang, Yi-Nan Liu, Ya-Ting Zeng, Yi-Rong Zheng, Qiang ChenFujian Children’s Hospital, Shanghai Children’s Medical Centerand Fujian Medical University.China Italian Journal of PediatricsItal J Pediatr 2024; 50: DOI: 10.1186/s13052-024-01821-8 AbstractBackground: The aim of this study is to summarize our center’s experience with patent ductus arteriosus (PDA) ligation during extracorporeal membrane oxygenation (ECMO) treatment in newborns with severe

Experience of patent ductus arteriosus ligation during extracorporeal membrane oxygenation treatment in newborns with severe respiratory failure due to persistent pulmonary hypertension: a single-center retrospective study Read More »

Left-Sided Atrioventricular Valve Regurgitation After the Repair of Complete Atrioventricular Septal Defect

Takaya Hoashi, Akinori Hirano, Ryusuke Hosoda, Haruhiro Nagase, Yuji Fuchigami, Yukino Iijima, Takaaki SuzukiSaitama Medical University International Medical Center.Japan Pediatric CardiologyPediatr Cardiol 2024; DOI: 10.1007/s00246-024-03707-2 AbstractThis study aimed to investigate left-sided atrioventricular valve outcome after the repair of complete atrioventricular septal defect from single-institutional retrospective chart review. From 1998 to 2022, 55 patients with complete atrioventricular

Left-Sided Atrioventricular Valve Regurgitation After the Repair of Complete Atrioventricular Septal Defect Read More »

Two-Year Outcomes in Preterm Infants Suffering from Moderate to Severe Bronchopulmonary Dysplasia with or without Associated Pulmonary Hypertension

Irina Branescu, Dragos Ovidiu Alexandru, Simona Vladareanu, Anay KulkarniCarol Davila University of Medicine and Pharmacy. St. George’s University Hospital and St George’s University. University of Medicine and Pharmacy. Royal Brompton Hospital NHS Foundation Trust.Romania and United Kingdom Current Health Sciences JournalCurr Health Sci J 2024; 50: 436-443DOI: 10.12865/CHSJ.50.03.11 AbstractObjectives: To assess the impact of pulmonary hypertension (PH)

Two-Year Outcomes in Preterm Infants Suffering from Moderate to Severe Bronchopulmonary Dysplasia with or without Associated Pulmonary Hypertension Read More »

Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension

Lene Nygaard Axelsen, Anne Kümmel, Juan Jose Perez Ruixo, Alberto RussuActelion Pharmaceuticals and Johnson & Johnson, Allschwil. Janssen-Cilag S.p.A.Switzerland, Spain and Italy Clinical Pharmacology and Therapeutics: Pharmacometrics and Systems PharmacologyCPT Pharmacometrics Syst Pharmacol 2024;DOI: 10.1002/psp4.13231 AbstractSelexipag is an oral selective prostacyclin receptor agonist approved for the treatment of pulmonary arterial hypertension (PAH) in adults. To date,

Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension Read More »

When pulmonary arterial hypertension and pregnancy meet: a multidisciplinary clinical experts review

Mattia Dominoni, Chiara Melito, Sandra Schirinzi, Stefano Ghio, Laura Scelsi, Alessandra Greco, Annalisa Turco, Federica Broglia, Marinella Fuardo, Maria Paola Delmonte, Francesca Perotti, Barbara Gardella, Arsenio SpinilloUniversity of Pavia. IRCCS Foundation Policlinico San Matteo. Italy Archives of Gynecology and ObstetricsArch Gynecol Obstet 2024; DOI: 10.1007/s00404-024-07827-1 AbstractPulmonary hypertension (PH) is a rare condition characterized by elevated pulmonary

When pulmonary arterial hypertension and pregnancy meet: a multidisciplinary clinical experts review Read More »

Persistent pulmonary hypertension in children after apparent resolution of ultrasound-defined pulmonary hypertension associated with bronchopulmonary dysplasia

Mami Takeoka, Hirofumi Sawada, Yoshihide Mitani, Hiroyuki Ohashi, Noriko Yodoya, Kazunobu Ohya, Naoki Tsuboya, Tomoya Harada, Masahiro HirayamaMie University Graduate School of Medicine. Japan European Journal of PediatricsEur J Pediatr 2024; 184: DOI: 10.1007/s00431-024-05843-6 AbstractTo evaluate pulmonary hemodynamics in patients who had been followed up for bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) in the mid-term by

Persistent pulmonary hypertension in children after apparent resolution of ultrasound-defined pulmonary hypertension associated with bronchopulmonary dysplasia Read More »

Asymmetric right ventricular myocardial work correlates with gold standard measurements of cardiac function in pulmonary hypertension

Simone G. Diab, Ryota Ebata, Dariusz Mroczek, Wei Hui, Espen W. Remme, Thomas Möller, Mark K. FriedbergOslo University Hospital and University of Oslo. Chiba University. Hospital for Sick Children.Norway and Japan Pulmonary CirculationPulm Circ 2024; 14: DOI: 10.1002/pul2.70014 AbstractRight ventricular (RV) (dys)function determines outcomes in pulmonary hypertension (PH). We previously found that asymmetric RV myocardial work

Asymmetric right ventricular myocardial work correlates with gold standard measurements of cardiac function in pulmonary hypertension Read More »

Scroll to Top